NCT04446416 2023-09-06Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsNaviFUS CorporationPhase NA Completed6 enrolled
NCT03626896 2019-06-21Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) PatientsNaviFUS CorporationPhase NA Completed6 enrolled